PKM and metabolic disease: Further, inhibition of adipocyte glycolysis and PKM2 function showed a stronger impact on pro-inflammatory cytokine production in white adipocytes from individuals living with obesity and metabolic disease compared with metabolically healthy individuals living with obesity.